San Francisco, California
London, United Kingdom
Statement of Need:
The last several years have seen rapid advances in the field of retinal imaging. We have witnessed widespread adoption of fundus autofluorescence and spectral domain OCT and, shortly, swept source OCT devices as well. Additionally, adaptive optics is becoming a more common way to image the retinal microstructure. Several new ultra-widefield imaging systems are scheduled to be released in the upcoming year. Additional new technology such as hyperspectral imaging and tools to noninvasively evaluate the retinal microvasculature are soon to follow. It is critical that retinal specialists remain up-to-date on these emerging technologies in order to provide the best care for their patients. As these new devices are technically complex, and the subtleties of interpretation of the acquired images is challenging, it is important to have instructional courses such as the IRIS II meeting available to the clinicians who will be using this complex technology.
North Shore-LIJ Health System CME activities are intended to improve patient care, safety, and outcomes.
Objective 1: Summarize new innovations of Optical Coherence Tomography (OCT) including swept source OCT so course participant may enhance skill in management of retinal /choroidal disorders such as choroidal tumors.
Objective 2: Discuss the benefits of wide field angiography such as wide field indocyanine and fluorescein angiography which may improve course participant’s understanding and management of various retinal/choroidal diseases such as central serous retinopathy and retinal vascular diseases.
Objective 3: Summarize new advancements of OCT that allow a better understanding of retinal anatomy and structure and morphology which may improve insight and understanding of course participant of the various macular diseases such as age related macular degeneration and ischemic disorders of the retina and may also improve therapies.
Objective 4: Discuss a multimodal imaging approach to the management of various retinal diseases such as neovascular age related macular degeneration which may improve treatment outcomes and decrease blindness.
Ophthalmologists, with an interest in the management of vitreous, retina and macular disease.
North Shore-LIJ Health System is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians.
North Shore-LIJ Health System designates this live activity for a maximum of 7.5 AMA PRA Category 1 creditsTM. Physicians should claim credit commensurate only to the extent of their participation in the activity.
Verification of Attendance:
Verification will be provided to all professionals attending the conference.
Faculty Disclosure Policy:
North Shore-LIJ Health System adheres to the ACCME’s New Standards for Commercial Support. Individuals in a position to control the content of a CME activity, including faculty, planners and managers are required to disclose all financial relationships with commercial interests. All identified potential conflicts of interest are thoroughly vetted by North Shore-LIJ for fair balance and scientific objectivity and to ensure appropriateness of patient care recommendations.
All cancellations must be confirmed in writing to:
NSLIJ/ MEETH L.T. Mertz Retinal Research Center
210 East 64th Street
New York, N.Y. 10065
Attention: Doreen Devivo
by Monday, June 9, 2014. An administrative fee of $50 will be retained. There will be no refunds after this date.
Americans with Disabilities Act:
This conference is in compliance with provisions of the Americans with Disabilities Act (ADA) and is accessible for individuals with special needs. If you would like to attend this conference and require any special needs or accommodations, please contact the Office of CME at 516-465-3263.
Anita Agarwal, M.D. United States
Francesco Bandello, M.D. Italy
Gaetano R. Barile, M.D. United States
Alexander J. Brucker, M.D. United States
Joseph Carroll, Ph.D. United States
Antonio Ciardella, M.D. Italy
Rogerio A. Costa, M.D., Ph.D. Brazil
Emmett T. Cunningham, Jr., M.D., Ph.D., M.P.H. United States
Christine Curcio, M.D. United States
Jay Duker, M.D. United States
Justis P. Ehlers, M.D. United States
Michael Engelbert, M.D., Ph.D. United States
Amani Fawzi, M.D. United States
Jasmine Francis, M.D. United States
K. Bailey Freund, M.D. United States
James G. Fujimoto, Ph.D. United States
Alain Gaudric, M.D. France
Tomohira Iida, M.D., Ph.D. Japan
Lee Jampol, M.D. United States
Szilard Kiss, M.D. United States
Hideki Koizumi, M.D., Ph.D. Japan
Michael Larsen, M.D. Denmark
Brandon J. Lujan, M.D. United States
H. Richard McDonald, M.D. United States
Edoardo Midena, M.D., Ph.D., FARVO, FEBO Italy
William Mieler, M.D. United States
Kyoko Ohno-Matsui, M.D. Japan
Jose Pulido, M.D. United States
Giuseppe Querques, M.D., Ph.D. France
Richard Rosen, M.D. United States
Philip Rosenfeld, M.D., Ph.D. United States
SriniVas Sadda, M.D. United States
David Sarraf, M.D. United States
Ursula Schmidt-Erfurth, M.D. Austria
Carol Shields, M.D. United States
Jerry Shields, M.D. United States
Lawrence J. Singerman, M.D. United States
Jason S. Slakter, M.D. United States
R. Theodore Smith, M.D., Ph.D. United States
Richard F. Spaide, M.D. United States
Giovanni Staurenghi, M.D. Italy
Stephen Tsang, M.D., Ph.D. United States
Lawrence A. Yannuzzi, M.D. United States
See the full UPDATED IRIS-II NEW YORK program HERE
We offer discounted rates at the following hotels:
If you make your reservations by phone, be sure to let them know that you’re with the “Retinal Research Group” in order to receive the preferred rate.
215 East 64th Street
New York, NY 10065
(64th Street between 2nd and 3rd Avenues)
Check-In: 3pm Check-Out: Noon
155 East 50th Street
New York, NY 10022
(50th Street at 3rd Avenue)
Check-In: 3pm Check-Out: Noon
When & Where
NSLIJ / MEETH L.T. Mertz Retinal Research Center
The LuEsther T. Mertz Retinal Research Center is a non-profit organization who's goal is to establish successful forms of treatment and the prevention and cure of Retinal Diseases, the major cause of legal blindness in the United States. With that objective in mind, the Center is involved in clinical research trials, educational and teaching programs as well as outreach and public awareness efforts.
The LuEsther T. Mertz Retinal Research Center is located at the prestigeous Manhattan Eye, Ear & Throat Hospital (MEETH) located at 210 East 64th Street in Manhattan, New York, and is primarily funded by The Macula Foundation, Inc.
In addition to sponsoring research, teaching, and outreach projects, the Center actively encourages the exchange of ideas among doctors and scientists who are engaged in similar research. The Center brings people together by regularly organizing meetings, lectures, and symposia. The Center also helps manage the publication and distribution of material related to retinal research.
IRIS-II NEW YORK
K. Bailey Freund, M.D.
David Sarraf, M.D.
IRIS-II NEW YORK
SriniVas Sadda, M.D.
Richard F. Spaide, M.D.
Lawrence A. Yannuzzi, M.D.